Atopic dermatitis (AD) is the most commonly diagnosed skin condition in dogs, and for the twelfth consecutive year it topped Nationwide’s annual pet insurance claims report — with over 410,500 individual claims in the US in 2023 alone. It affects an estimated 10–15% of the dog population, has no cure, and requires lifelong multimodal management. Despite its prevalence, canine atopic dermatitis is one of the conditions where client compliance with ongoing management most frequently falls apart — because the treatment is complex, the medications are expensive, the response is gradual, and the condition flares even when management is optimal. A structured follow-up protocol is the primary mechanism clinics have for keeping owners engaged over the long term.
Why atopic dermatitis follow-up is a compliance challenge above all else
The treatment of canine atopic dermatitis typically involves a combination of approaches: allergen-specific immunotherapy, medications to control pruritus and inflammation (oral glucocorticoids, ciclosporin, oclacitinib, lokivetmab, or newer JAK inhibitors), topical treatments and medicated shampoos, and management of secondary bacterial and yeast infections. In practice, this means owners managing multiple medications at varying frequencies, adhering to bathing schedules, and potentially conducting food elimination trials for concurrent food allergies — with strict dietary compliance for a minimum of 6–8 weeks.
Research on owner adherence in chronic veterinary conditions consistently shows that compliance drops significantly over time without active reinforcement. For atopic dermatitis specifically, a study tracking adherence using a mobile health app found that the chronic nature of CAD, the frequency of medication administration, and the lack of visible cure were the primary drivers of compliance challenges. Allergen-specific immunotherapy — which requires subcutaneous injections for months before clinical response is typically seen — is particularly prone to premature discontinuation: the average clinical response occurs between 6 and 8 months, but response rates vary enough that ICADA guidelines recommend continuing for at least 12 months before evaluating efficacy.
The secondary infection risk adds further clinical complexity. Dogs with atopic dermatitis frequently develop bacterial (Staphylococcus pseudintermedius) and yeast (Malassezia) secondary infections that significantly worsen clinical signs. These are not always apparent to owners and can be missed between appointments if follow-up is infrequent.
The atopic dermatitis follow-up timeline
| Timepoint | What to check | Red flags |
|---|---|---|
| 2–4 weeks post-treatment initiation | Initial response to medication, any side effects from new drugs (ciclosporin GI effects, steroid PU/PD), bathing schedule adherence, owner confidence | No improvement in pruritus after 4 weeks on an appropriate drug — reassess diagnosis or dose; GI side effects with ciclosporin |
| 6–8 weeks | Reassessment of pruritus score, secondary infection check (owner-observed increase in scratching, ear odour, skin odour), food trial compliance if applicable | Worsening despite treatment — consider secondary infection, inadequate dose, or concurrent trigger (fleas, food) |
| 3–6 months | Immunotherapy compliance and any early clinical response, long-term medication tolerance, seasonal flare assessment, quality of life for dog and owner | Owner has stopped immunotherapy before 6-month assessment period, significant quality-of-life impact on dog or household |
| Ongoing (every 3–6 months) | Seasonal flare monitoring, medication adjustment as needed, flea control compliance, ear canal health | Persistent or worsening secondary infections, owner disengaging from management plan |
What to ask owners during atopic dermatitis follow-up
- Has [dog name]‘s scratching, licking, or chewing reduced since starting treatment?
- Are you giving all medications consistently — at the right dose and frequency?
- Have you noticed any side effects — increased thirst, urination, vomiting, or diarrhoea?
- Are you sticking to the recommended bathing schedule and using the prescribed shampoo?
- Does the skin or ears smell unusual, or has she been shaking her head or scratching at her ears?
- Has there been a seasonal change (pollen season, change in weather) that seems to have made things worse?
- Is she on strict flea prevention, and has she been exposed to any potential flea environments?
- If on a food trial: have you been strictly avoiding all other foods, treats and flavoured medications?
- If on immunotherapy: have you been giving the injections on schedule, and have you seen any changes?
- How would you rate her overall comfort and quality of life compared to when you first came in?
Common atopic dermatitis follow-up mistakes clinics make
Not distinguishing between “not working” and “too early to assess.” Owners who see little improvement at 6 weeks on ciclosporin or immunotherapy may conclude the treatment isn’t working and stop. A follow-up call that contextualises the expected response timeline — immunotherapy typically requires 6–12 months — prevents premature discontinuation that would otherwise lead to another appointment cycle from scratch.
Missing secondary infections between appointments. A dog that was well-managed at the last appointment but has developed a secondary Staphylococcus or Malassezia infection in the intervening months will have significantly worsening clinical signs that the owner attributes to the underlying allergy rather than an additional treatable infection. A follow-up call that directly asks about skin odour and ear health catches these before the next scheduled appointment.
Not following up during known seasonal trigger periods. Many atopic dogs have seasonal flares driven by pollen or other environmental allergens — 40–75% of cases have a seasonal component at onset, which can progress to year-round over time. A follow-up call during a known high-risk period (spring pollen season, for example) for a known seasonal atopic dog is high clinical value for minimal effort.
How to automate atopic dermatitis follow-up without adding to your team’s workload
Nidana Loop schedules follow-up calls at the 2-week and 6-week marks post-treatment change, and at seasonal risk periods for known atopic dogs based on the discharge notes. The calls ask about pruritus score, medication compliance, and secondary infection signs. For dogs on immunotherapy, Loop flags the 6-month mark as a clinical review point. The clinic sees a summary and a flag for cases needing prompt attention.
See how Loop handles atopic dermatitis follow-up calls → Book a 20-minute demo
Related: Ear infection follow-up protocol · Flea allergy dermatitis follow-up · Hot spot aftercare protocol